CarlKoschmannMD

Pediatric Hematology & Oncology • Ann Arbor, MI

Pediatric Neuro-Oncology

Associate Professor

Join to view full profile

Dr. Koschmann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Koschmann's full profile

Already have an account?

Office
1500 E Medical Center Dr
Ann Arbor, MI 48109
Phone+1 734-936-4000

Summary

The Koschmann Lab

The Koschmann lab is studying the molecular mechanisms by which mutations in pediatric High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG) can be ther

Education & Training

University of Michigan Health SystemPost-Doctoral Fellowship, Pediatric Neuro-Oncology, 2014 - 2015
University of MichiganFellowship, Pediatric Hematology/Oncology, 2011 - 2014
University of WashingtonResidency, Pediatrics, 2007 - 2010
University of Wisconsin School of Medicine & Public HealthClass of 2007

Certifications & Licensure

MI State Medical License 2011 - 2027
WA State Medical License 2007 - 2016
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations Start of enrollment: 2017 Dec 06
Terminated
Phase 2
Fimepinostat in Treating Brain Tumors in Children and Young Adults Start of enrollment: 2019 Aug 07
Active, not recruiting
Early Phase 1
Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma Start of enrollment: 2019 Nov 30
Withdrawn
Early Phase 1

Publications & Presentations

PubMed

Retrospective Comparison of Targeted Anticancer Drugs Predicted by the CNS-TAP Tool Versus Those Selected by a Molecularly Driven Tumor Board in Children With DIPG.
Holly J Roberts, Karthik Ravi, Bernard L Marini, Allison Schepers, Cassie Kline
Journal of Pediatric Hematology/oncology. 2024-11-06
Long-Term Tumor Stability After First-Line Treatment With Larotrectinib in an Infant With NTRK2 Fusion-Positive High-Grade Glioma.
Jillian Simoneau, Patricia Robertson, Karin Muraszko, Cormac O Maher, Hugh Garton
Journal of the National Comprehensive Cancer Network. 2024-09-01
1 citations
GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant.
Ilon Liu, Gustavo Alencastro Veiga Cruzeiro, Lynn Bjerke, Rebecca F Rogers, Yura Grabovska
Cancer Cell. 2024-08-27

Press Mentions

Chimerix Announces Presentation of Multiple Imipridone Datasets at American Association for Cancer Research Annual MeetingApril 19th, 2023
For Glioma Patients, a Mutated Gene May Open the Door to New Treatment OptionsJanuary 18th, 2022
Prayers from Maria Has Raised More Than $7 Million for Cancer ResearchJanuary 25th, 2021
Join now to see all